September 29, 2017 – Primary Care Doctor (Dr. F) finds a lump in my right breast
November 9, 2017 – Right breast ultrasound; bilateral breast mammogram; right breast biopsy
November 14, 2017 – Breast cancer diagnosis is confirmed through biopsy results
November 17, 2017 – Bilateral Breast MRI
November 27, 2017 – Second opinion appointment at Cancer Center; possibility of metastatic disease discovered
November 28, 2017 -1st PET/CT Scan at Cancer Center; likelihood of metastatic breast cancer based on preliminary results
December 8, 2017 – Consultation with Interventional Radiologist for bone biopsy
December 13, 2017 – Bone biopsy to confirm metastatic disease
December 18, 2017 – Confirmation of metastatic disease to bones; treatment plan meeting with Dr. G; treatment started: Xgeva, Lupron, letrozole
January 15, 2018 – Second doses of Xgeva, Lupron received; first follow up with Dr. G at Cancer Center
January 18, 2018 – Start Ibrance 1st cycle, continue Xgeva, Lupron, and letrozole
February 15, 2018 – Start Ibrance 2nd cycle, continue Xgeva, Lupron, and letrozole
March 15, 2018 – Start Ibrance 3rd cycle, continue Xgeva, Lupron, and letrozole
March 19-25, 2018 – Skip 1 week of Ibrance due to persistent sinus infection
April 2, 2018 – 2nd PET/CT Scan at Cancer Center; results show shrinking tumors and less metabolic activity
April 12, 2018 – Start Ibrance 4th cycle, continue Xgeva, Lupron, and letrozole
May 10, 2018 – Start Ibrance 5th cycle, continue Xgeva, Lupron, and letrozole
June 7, 2018 – Start Ibrance 6th cycle, continue Xgeva, Lupron, and letrozole
July 5, 2018 – Start Ibrance 7th cycle, continue Xgeva, Lupron, and letrozole
June 26, 2018 – 3rd PET/CT Scan; results stable
August 2, 2018 – Start Ibrance 8th cycle, continue Xgeva, Lupron, and letrozole
August 23, 2018 – Total laparoscopic hysterectomy with salpingo-oophorectomy
August 30, 2018 – Start Ibrance 9th cycle, continue Xgeva and letrozole
September 18, 2018 – 4th PET/CT Scan; results stable
September 27, 2018 – Start Ibrance 10th cycle, continue Xgeva and letrozole
October 25, 2018 – Start Ibrance 11th cycle, continue Xgeva and letrozole
November 22, 2018 – Start Ibrance 12th cycle, continue Xgeva and letrozole
December 11, 2018 – 5th PET/CT Scan; results show bone progression; continue Xgeva
December 21, 2018 – Sign consent forms for clinical trial, 2nd line of treatment
December 31, 2018 –
Beyond the Pink Ribbon 